Siemens Healthcare has added new functions to Syngo Embolization Guidance to simplify and accelerate the minimally invasive embolization of benign tumors such as myomas. The new version of the imaging software assists with treatment planning and delivery and makes it possible to check treatment outcomes. Syngo Embolization Guidance can speed up interventions as compared with previous embolization procedures, meaning that both contrast medium and dose can be reduced. This makes the occlusion of the blood vessels supplying the myoma easier on the patient than conventional methods.
The new version of Syngo Embolization Guidance from Siemens enables physicians to mark both the myoma and the blood vessels supplying the tumor on the pre-intervention CT (computed tomography) or MRT (magnetic resonance tomography) images. The software calculates the tumor volume and the access path to the myoma for the catheter automatically and shows both in the 3D planning image. Superimposing this image on the live fluoroscopic image during the intervention enables the radiologist to position the catheter easier than has previously been the case and largely removes the need for contrast medium, as the path is already marked and segmented in the 3D image. Treating myomas with Syngo Embolization Guidance is thus easier on the patient. Myomas (uterine leiomyomas) are benign thickenings of the myometrium. The Robert Koch Institute explains in its reporting to the German Federal Health Monitoring System in 2007 that myomas occur in significant numbers in around one third of women from the age of 35 onward in our part of the world1.
The traditional technique for myoma treatment involves the surgical removal of the tumors in an operation. A new minimally invasive method involving the occlusion of blood vessels has become established over recent years. Known as embolization, this technique sees a catheter inserted into the patient's vascular system through a very small access point, usually in the groin, and guided to the tumor. The catheter is navigated through the blood stream using a fluoroscopy system. The position of the catheter in the patient's body is displayed on screen in 2D images from an angiography unit, with contrast medium helping to make the area of interest stand out from the surrounding tissue. Key to this technique is the ability to bring the catheter into a position from which the blood vessels supplying the tumor can be occluded. Once the catheter is in place, emboli, for example very small particles of plastic, are injected directly into the blood vessels that supply the myoma until the blood supply to the benign tumor has been stopped. Deprived of essential nutrients and oxygen, the myomas shrink and eventually die.
The product mentioned herein is not commercially available. Due to regulatory reasons its future availability cannot be guaranteed.
The Siemens Healthcare Sector is one of the world’s largest healthcare solution providers and a leading manufacturer and service provider in the fields of medical imaging, laboratory diagnostics, hospital information technology and hearing instruments. It offers solutions covering the entire supply chain under one roof - from prevention and early detection to diagnosis and on to treatment and aftercare. By optimizing clinical workflows oriented toward the most important clinical pictures, Siemens also strives to make healthcare faster, better and, at the same time, less expensive. Siemens Healthcare currently has some 48,000 employees worldwide and is present throughout the world. During fiscal 2010 (up to September 30) the Sector posted sales worth 12.4 billion euros and profits of around 750 million euros.
1 Robert Koch Institute, Ed.: Vol. 37 Gebärmuttererkrankungen [Hysteropathy], from the series "Gesundheitsberichterstattung des Bundes" [German Federal Health Monitoring], Berlin, January 2007
Marion Bludszuweit | Siemens Healthcare
UTSA study describes new minimally invasive device to treat cancer and other illnesses
02.12.2016 | University of Texas at San Antonio
Earlier Alzheimer's diagnosis may be possible with new imaging compound
02.11.2016 | Washington University School of Medicine
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy